Shyam Medical Stores

Lenalid 15 Capsule contains Lenalidomide, an immunomodulatory agent that is primarily used in the treatment of certain types of cancers, including multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma. Lenalidomide works by affecting the immune system to inhibit the growth of cancer cells, promote the destruction of abnormal cells, and reduce the formation of blood vessels that supply tumors.

Common indications for Lenalid 15 Capsule include:

• Multiple Myeloma: Used in combination with other medications to treat multiple myeloma, particularly in patients who have received at least one prior therapy.
• Myelodysplastic Syndromes (MDS): Used to treat certain types of MDS, especially in patients with a specific chromosomal abnormality.
• Mantle Cell Lymphoma: Used in patients whose disease has relapsed or progressed after two prior therapies, including bortezomib.

Dosage and Administration:

• For Adults: The dosage of Lenalid 15 Capsule varies depending on the condition being treated. The exact dosage regimen should be determined by a healthcare provider based on individual patient factors and response to treatment.
• Administration: The capsule should be swallowed whole with water, with or without food. It is important to follow the prescribed schedule and not to break, chew, or open the capsules.

Common side effects of Lenalid 15 Capsule may include:

• Fatigue
• Anemia
• Neutropenia (low white blood cell count)
• Thrombocytopenia (low platelet count)
• Diarrhea
• Rash

Due to the risk of serious side effects, including birth defects, Lenalidomide is subject to special safety monitoring and prescribing programs. Patients should discuss all potential risks and benefits with their healthcare provider.

.

Cycloxan 500 mg Injection contains Cyclophosphamide, an anti-cancer (antineoplastic) medication from the alkylating agent class. It works by slowing or stopping the growth of cancer cells. It's administered via injection under medical supervision, typically in chemotherapy regimens. Cyclophosphamide is also used to suppress the immune system in cases of severe autoimmune conditions.

Commonly available under brand names such as Cycloxan, Endoxan, and Cytoxan, this drug is widely used for treating various types of cancer and certain autoimmune diseases

• Mab Thera is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.

L-asparaginase is primarily used to treat acute lymphoblastic leukemia (ALL), a type of blood cancer. It works by breaking down asparagine, an amino acid that leukemia cells need to grow. Normal cells can produce their own asparagine, so they are less affected. It may also be used for other types of cancer as determined by a doctor.  

Palnat 125 Capsule contains Palbociclib, a targeted cancer therapy known as a cyclin-dependent kinase (CDK) 4/6 inhibitor. It is used in combination with hormonal therapies to treat hormone receptor-positive, HER2-negative breast cancer. Palbociclib works by inhibiting the activity of CDK4 and CDK6, which are enzymes that promote cell division. By blocking these enzymes, Palbociclib slows the growth and spread of cancer cells.

Common indications for Palnat 125 Capsule include:

• Breast Cancer: Used in combination with an aromatase inhibitor as the first-line treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer in postmenopausal women. It is also used with fulvestrant in patients whose disease has progressed after endocrine therapy.

Dosage and Administration:

• For Adults: The recommended dose is 125 mg taken orally once daily for 21 consecutive days, followed by 7 days off treatment, making up a 28-day cycle.
• Administration: The capsule should be swallowed whole with water, preferably with food. It should not be chewed, crushed, or opened.

Common side effects of Palnat 125 Capsule may include:

• Neutropenia (low white blood cell count)
• Fatigue
• Nausea
• Diarrhea
• Infections
• Stomatitis (inflammation of the mouth)
• Thrombocytopenia (low platelet count)

Patients are advised to undergo regular blood tests to monitor blood cell counts during treatment, as well as to report any signs of infection or unusual symptoms to their healthcare provider immediately.

Packaging:
Palnat 125 Capsule is typically packaged in blister packs containing 21 capsules, which corresponds to one cycle of treatment.

Palnat 125 Capsule is an important medication in the treatment of advanced breast cancer, offering a targeted approach that, when used in combination with hormonal therapies, can help control the disease and improve survival outcomes. Adherence to the prescribed regimen and regular monitoring are essential to maximize the benefits of this therapy while managing potential side effects.

Tykerb 250 mg Tablet contains Lapatinib, a tyrosine kinase inhibitor used in the treatment of HER2-positive breast cancer. Lapatinib targets specific receptors involved in cancer cell growth, particularly the human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR). By inhibiting these receptors, Tykerb helps to slow down or stop the growth of cancer cells.

Common indications for Tykerb Tablet include:

• HER2-Positive Breast Cancer: Tykerb is used in combination with other medications, such as capecitabine or letrozole, to treat HER2-positive metastatic breast cancer that has not responded to previous therapies.

Dosage and Administration: The usual dosage of Tykerb is determined by the healthcare provider based on the patient’s specific condition and response to treatment. It is important to follow the prescribed dosage and administration schedule as directed.

Xmalon 25mg Tablet is also used in combination with medication in early cancer to prevent the risk of coming back. It should be taken with food, but take it at the same time every day to get the most benefit. It should be taken as your doctor's advice. The dose and how often you take it depends on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. Swallow the tablets whole with a drink of water. You should take this medicine for as long as it is prescribed for you.

The most common side effects of the medicine include insomnia (difficulty sleeping), headache, nausea, increased appetite, and joint pain  If these bother you, or appear serious, let your doctor know. There may be ways of reducing or preventing them.

Nubeqa 300mg tablet consists of the active ingredient Darolutamide. It is an androgen receptor inhibitor used for treating adult men with non-metastatic castration-resistant prostate cancer. It is also approved to treat hormone-sensitive metastatic prostate cancer in combination with other anti-cancer medications. Prostate cancer occurs when the prostate cells start multiplying and dividing abnormally. Do not take this medicine if you are allergic to darolutamide or any other ingredient in it.    

Effective contraception is to be taken while using Nubeqa 300mg Tablet, and it must be continued till one week after the last dose with this medication to prevent pregnancy. Before starting treatment with this medication, inform your doctor if you have any liver problems, kidney problems, heart conditions, or allergic conditions.  

Nubeqa 300mg tablet may cause infertility in men, hence discuss your fertility concerns with your doctor before beginning treatment with this medication. Inform your doctor if you are lactose intolerant before starting treatment with this medication, as it contains lactose. Fatigue, rash, and pain in muscle, bone, arms, and legs are common side effects of this medication. 

Tretinoin CA Atra 10mg Softgel Capsules contain Tretinoin, a derivative of vitamin A, also known as all-trans retinoic acid (ATRA). This medication is used primarily in the treatment of acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia. Tretinoin works by promoting the differentiation of immature blood cells into normal cells, helping to restore normal blood cell production.

In addition to its use in treating APL, Tretinoin is also prescribed for the management of severe acne that has not responded to other treatments. It works by promoting skin cell turnover, reducing the formation of acne and unclogging pores.

Tretinoin softgel capsules are typically part of a combination therapy, particularly in APL treatment, and they are often used alongside other chemotherapy agents. Regular monitoring by a healthcare provider is essential during treatment, and it may take some time to observe the full therapeutic effects

Anaridex (Anastrozole) is a potent aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women. By lowering estrogen levels, Anastrozole helps slow down or stop the growth of cancer cells that rely on estrogen to grow.

Indications:

• Hormone receptor-positive breast cancer in postmenopausal women
• Adjuvant treatment of early breast cancer
• Treatment of advanced breast cancer

 Silofast 8mg Capsules contain Silodosin 8mg, a selective alpha-1 adrenergic receptor antagonist that is primarily used to treat symptoms of benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland in men. By relaxing the muscles in the prostate and bladder neck, Silodosin helps relieve symptoms such as difficulty in urination, a weak urine stream, and frequent or urgent urination, allowing smoother urine flow.

Silofast is highly effective in improving urinary symptoms and quality of life for men with BPH. It specifically targets the alpha-1A receptors in the prostate, minimizing the effect on blood pressure compared to other alpha-blockers. This makes it suitable for older patients or those with comorbidities.

Common side effects include dizziness, retrograde ejaculation (where semen enters the bladder instead of exiting through the penis), and a runny or stuffy nose. It is advised to take the capsule with food to reduce the risk of side effects, and patients should avoid operating heavy machinery or driving until they know how the medication affects them.

Silofast 8mg should be used under medical supervision, and patients are encouraged to consult their healthcare provider if they experience any severe side effects or if their symptoms do not improve. Regular follow-ups may be necessary to monitor the progression of BPH and the effectiveness of the treatment.

The 100mg Nivolumab Opdyta injection contains nivolumab. Nivolumab is an immunotherapy medication that works by helping your body's immune system to fight cancer. It is classified as a checkpoint inhibitor. Opdyta (nivolumab) is used in the treatment of several different types of cancer, including non-small cell lung cancer, melanoma (a type of skin cancer), kidney cancer (renal cell carcinoma), Hodgkin lymphoma, head and neck cancer, liver cancer (hepatocellular carcinoma), bladder cancer (urothelial carcinoma), esophageal cancer, and gastric cancer. It can be used on its own or in combination with other cancer therapies.

Tagrisso 80mg Tablet contains Osimertinib, a targeted cancer therapy used in the treatment of non-small cell lung cancer (NSCLC) that has specific mutations in the epidermal growth factor receptor (EGFR). Osimertinib is an EGFR tyrosine kinase inhibitor (TKI) that works by blocking the activity of the mutated EGFR, which drives the growth and spread of cancer cells. It is particularly effective against NSCLC that has developed resistance to other EGFR inhibitors.

Common indications for Tagrisso 80mg Tablet include:

• Cancer Treatment: Used in the management of non-small cell lung cancer (NSCLC) with specific EGFR mutations.

Dosage and Administration:

• For Adults: The typical dose is one 80 mg tablet taken orally once daily. The exact dosage and duration of treatment are determined by the oncologist based on the patient's condition and response to therapy.
• Administration: Tagrisso should be taken with or without food, and at the same time each day.

Carfilzomib 60mg injection is a medication primarily used to treat multiple myeloma, a type of cancer affecting plasma cells in the bone marrow. It is used in patients who have already undergone previous treatments for this condition. In some instances, it may also be used to treat mantle cell lymphoma.

Carfilzomib belongs to a class of drugs called proteasome inhibitors. It works by blocking the action of proteasomes, which are responsible for breaking down proteins in cells. By inhibiting proteasomes, carfilzomib leads to a buildup of proteins within the cancer cells, eventually causing them to die.

Ondem 4 Tablet contains Ondansetron 4 mg, a selective serotonin 5-HT3 receptor antagonist. It is primarily used to prevent and treat nausea and vomiting associated with cancer treatments like chemotherapy and radiotherapy, as well as post-operative nausea. By blocking the actions of chemicals that can trigger nausea, Ondem helps ensure patient comfort during medical procedures.

Popular brands like Ondem, Emeset, and Zofran are commonly prescribed for managing nausea and vomiting across various clinical settings. Manufactured by Alkem Laboratories Ltd, Ondem 4 Tablet provides reliable support in preventing nausea and improving patient outcomes

Product Description:
Imbruvica 140mg Capsule contains Ibrutinib, a Bruton's tyrosine kinase (BTK) inhibitor used in the treatment of several types of blood cancers. Ibrutinib works by blocking BTK, a protein that helps cancer cells survive and grow. By inhibiting this protein, Imbruvica interferes with the growth and spread of cancer cells, particularly in certain types of leukemia and lymphoma.

Common indications for Imbruvica 140mg Capsule include:

• Chronic Lymphocytic Leukemia (CLL): Used as a first-line treatment or in patients who have received at least one prior therapy.
• Small Lymphocytic Lymphoma (SLL): Treated similarly to CLL, targeting the same type of cancer cells.
• Mantle Cell Lymphoma (MCL): Used in patients who have received at least one prior therapy.
• Waldenström's Macroglobulinemia (WM): A rare type of non-Hodgkin lymphoma treated with Imbruvica.
• Marginal Zone Lymphoma (MZL): Used in patients who have received prior treatment with at least one anti-CD20-based therapy.

Dosage and Administration:

• For Adults: The dosage varies depending on the condition being treated but typically involves taking multiple 140 mg capsules to reach a total daily dose of 420 mg or 560 mg, depending on the specific disease.
• Administration: The capsule should be swallowed whole with water, taken once daily at the same time each day. It should not be opened, crushed, or chewed.

Common side effects of Imbruvica 140mg Capsule may include:

• Diarrhea
• Fatigue
• Nausea
• Musculoskeletal pain
• Bruising
• Rash

Imbruvica may also increase the risk of infections and bleeding, so patients should be monitored closely by their healthcare provider throughout the course of treatment.